| Issue |
Title |
File |
| Vol 21, No 4 (2025) |
Possibilities of breast-conserving surgery in multicentric and multifocal forms of breast cancer |
(Rus)
|
|
Vats A.B., Lazakovich A.A., Dashyan G.A., Akhmedov R.M., Zhurov A.S., Shaykhelislamova L.F., Belousov A.M.
|
| Vol 21, No 4 (2025) |
Interval breast cancer: current state of the problem |
(Rus)
|
|
Kayukova E.V., Gorbacheva O.N.
|
| Vol 21, No 4 (2025) |
Clinical and diagnostic features of lobular breast cancer |
(Rus)
|
|
Vysotskaya I.V., Kim E.A., Denchik D.A., Struts I.S., Golovina E.A., Shevkunova A.V.
|
| Vol 21, No 4 (2025) |
From clinical trials to routine practice: 7-year results of the monarchE randomized clinical trial and experience with the use of abemaciclib in hormone-dependent, HER2-negative, high-risk, early breast cancer |
(Rus)
|
|
Kolyadina I.V., Khokhlova S.V., Bikeev Y.V., Zaytsev N.A., Poddubnaya I.V.
|
| Vol 21, No 3 (2025) |
Surgery of axillary lymph nodes in breast cancer in modern oncology |
(Rus)
|
|
Ismagilov A.K., Kamaletdinov I.F., Gubaydulin K.M., Gabdrakhmanova A.R.
|
| Vol 21, No 3 (2025) |
Preoperative hormone sensitivity test as a tool for personalizing systemic therapy in breast cancer patients |
(Rus)
|
|
Rodionova M.V., Rodionov V.V., Kometova V.V., Burmenskaya O.V., Bozhenko V.K., Ashrafyan L.A.
|
| Vol 21, No 2 (2025) |
Predictors of the formation of antitumor immunity in breast cancer patients and the analysis of the results of the use of immune checkpoint inhibitors |
(Rus)
|
|
Sultanbaev A.V.
|
| Vol 21, No 2 (2025) |
Modern concepts of basic therapy for diffuse dyshormonal dysplasia of the mammary glands |
(Rus)
|
|
Vуsotskaya I.V., Kim E.A., Kushnir M.A.
|
| Vol 21, No 2 (2025) |
The role of ribociclib in the treatment of early hormone receptor-positive HER2-negative breast cancer: 4-year results of the randomized controlled phase 3 trial NATALEE and their reconsideration for clinical practice |
(Rus)
|
|
Kolyadina I.V.
|
| Vol 21, No 2 (2025) |
The role of intraoperative and early postoperative assessment of skin flap perfusion in skin-sparing/subcutaneous mastectomies |
(Rus)
|
|
Keremov R.K., Zikiryakhodzhaev A.D., Usov F.N., Moshurova M.V., Dzhabrailova D.S., Naydina K.A.
|
| Vol 20, No 4 (2024) |
Installation of preoperative and intraoperative fiducial markers for radiation therapy in mammary gland surgery (literature review) |
(Rus)
|
|
Abdrakhmanova A.Z., Khvan N.S., Goncharova T.G., Sultanseitov S.S., Bayzhigitov A.B., Toguzbayeva A.Y., Kazhenova A.S., Khozhaev A.A., Aymanova D.E.
|
| Vol 20, No 4 (2024) |
Progesterone and progesterone receptors in breast cancer: past, present, and future |
(Rus)
|
|
Rodionova M.V., Rodionov V.V., Kometova V.V., Smetnik A.A., Kolyadina I.V., Burmenskaya O.V., Bozhenko V.K., Bikeev Y.V., Mikhaleva L.M., Ashrafyan L.A.
|
| Vol 20, No 3 (2024) |
The role of local and systemic control methods in the treatment of oligometastatic breast cancer, taking into account biological subtypes (literature review) |
(Rus)
|
|
Sevostyanova T.I., Semiglazova T.Y., Ponasenko O.I., Lyaschenko V.A., Abdullaeva S.R., Filatova L.V., Bryantseva Z.V., Kasparov B.S., Paltuev R.M., Semiglazov V.V., Krivorotko P.V., Novikov S.N., Semiglazov V.F.
|
| Vol 20, No 3 (2024) |
Features and complexity of treatment of BRCA-associated ovarian cancer, chronic disease: literature review |
(Rus)
|
|
Gorodnova T.V., Sokolenko A.P., Kotiv K.B., Berlev I.V., Imyanitov E.N.
|
| Vol 20, No 2 (2024) |
Prevention of the development of diastasis of the wound edges during two-stage breast reconstruction |
(Rus)
|
|
Ismagilov A.K., Kamaletdinov I.F., Akhmetzyanov A.M., Dobrov V.S., Gabdrakhmanova A.R.
|
| Vol 20, No 1 (2024) |
Sentinel lymph node biopsy in patients with breast cancer ycT4N0M0 after neoadjuvant drug therapy |
(Rus)
|
|
Kurbanova M.B., Frolova M.A., Shidakova F.K., Amosova V.A., Gagulaeva K.V., Margusheva M.A., Yangirova E.V., Petrovskiy A.V.
|
| Vol 20, No 1 (2024) |
Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literature review |
(Rus)
|
|
Avxentyev N.A., Andreyashkina I.I., Artamonova E.V., Bolotina L.V., Kovalenko E.I., Sisigina N.N.
|
| Vol 20, No 1 (2024) |
Mastalgia: current trends and recommendations |
(Rus)
|
|
Berishvili A.I., Greyan T.A., Zaytseva O.V., Pukhov A.A.
|
| Vol 20, No 1 (2024) |
Escalation of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer: to whom, when and why? |
(Rus)
|
|
Kolyadina I.V.
|
| Vol 19, No 4 (2023) |
Breast calcifications. Literature review |
(Rus)
|
|
Khodorovich O.S., Solodkiy V.A., Kleshneva V.O., Sherstneva T.V., Ishchenko K.V.
|
| Vol 19, No 3 (2023) |
Modern possibilities for the correction of menopausal symptoms in patients with breast cancer, depending on the molecular biological characteristics of the tumor (literature review) |
(Rus)
|
|
Vysotskaya I.V., Kim E.A., Geletko M.V., Misrikhanova F.E., Kirsanov V.Y.
|
| Vol 19, No 3 (2023) |
Netupitant/palonosetron (NEPA; Akynzeo®) combination in prevention of the nausea and vomiting in patients with breast cancer receiving anthracyclinbased chemotherapy |
(Rus)
|
|
Kedrova A.G., Berishvili A.I.
|
| Vol 19, No 3 (2023) |
Trastuzumab deruxtecan in the treatment of patients with advanced breast cancer with HER2-low expression: Recent studies review |
(Rus)
|
|
Kolyadina I.V.
|
| Vol 19, No 2 (2023) |
Breast cancer screening in germline mutation carriers. A literature review |
(Rus)
|
|
Sultanbaev A.V., Nasretdinov A.F., Galeev M.G., Menshikov K.V., Musin S.I., Sultanbaeva N.I., Ayupov R.T., Rakhimov R.R., Lipatov O.N., Izmaylov A.A., Menshikova I.A., Serebrennikov G.A., Lipatov D.O.
|
| Vol 19, No 1 (2023) |
Complications after reconstructive plastic surgery using allomaterials in patients with breast cancer according to domestic and world literature |
(Rus)
|
|
Troshenkov E.A., Zikiryakhodzhaev A.D., Kaprin A.D., Malik D.S.
|
| Vol 19, No 1 (2023) |
Utility of radiotherapy for the management of local tumor progression in patients with early breast cancer |
(Rus)
|
|
Gladilina I.A., Vysotskaya I. ., Chulkova S. ., Egorova A. ., Shabanov M.A., Fedoseenko D.I., Semichev D.G.
|
| Vol 19, No 1 (2023) |
Nausea and vomiting induced by pharmacotherapy: have all issues of maintenance therapy been resolved? |
(Rus)
|
|
Konstantinova M.M., Paltuev R. .
|
| Vol 18, No 3 (2022) |
Obesity and breast cancer |
(Rus)
|
|
Berishvili A.I., Kedrova A.G., Greyan T.A., Zaitseva O.V.
|
| Vol 18, No 3 (2022) |
MicroRNA-dependent mechanisms of taxane resistance in breast cancer |
(Rus)
|
|
Apollonova V.S., Sidina E.I., Tkachenko E.V., Malek A.V.
|
| Vol 18, No 3 (2022) |
The influence of synthetic and biologic matrices on the choice of the implant plane during breast reconstruction. The modern state of the problem |
(Rus)
|
|
Baychorov E.A., Zikiryakhodzhaev A.D., Ismagilov A.K., Przhedetskiy Y.V.
|
| Vol 18, No 4 (2022) |
Melatonin, circadian rhythms and breast cancer |
(Rus)
|
|
Eremenko I.I., Ponomarev V.E., Vysotskaya I.V., Polikarpova S.B., Bogush E.A., Kirsanov V.Y., Davydov M.M.
|
| Vol 18, No 4 (2022) |
Breast cancer screening in young women |
(Rus)
|
|
Kochetkova Y.I., Krashenkov O.P.
|
| Vol 18, No 4 (2022) |
Organ-sparing treatment for breast cancer |
(Rus)
|
|
Rasskazova E.A., Zikiryakhodzhaev A.D., Kaprin A.D.
|
| Vol 18, No 2 (2022) |
Effectiveness of mammography screening for women aged 40–49 |
(Rus)
|
|
Belaya Y.A.
|
| Vol 18, No 1 (2022) |
Current aspects of systematics, diagnosis and treatment of breast cancer |
(Rus)
|
|
Strunkin D.N., Kononchuk V.V., Gulyaeva L.F., Bogachev S.S., Proskurina A.S.
|
| Vol 18, No 1 (2022) |
A modern view at the differential ultrasound diagnosis of hyperechoic benign tumors of the breast |
(Rus)
|
|
Danzanova T.Y., Sinyukova G.T., Lepedatu P.I., Gudilina E.A., Kovaleva E.V., Kolyadina A.V.
|
| Vol 17, No 4 (2021) |
Questions of axillary region surgery in breast cancer patients after systemic neoadjuvant therapy |
(Rus)
|
|
Bozhok A.A., Tsarev O.N., Maysuradze S.A., Gil A.I.
|
| Vol 17, No 3 (2021) |
Autologous dura mater grafts in reconstructive surgeries for breast cancer patients |
(Rus)
|
|
Dzhabrailova D.S., Zikiryakhodzhaev A.D., Usov F.N., Starkova M.V., Bagdasarova D.V., Duadze I.S.
|
| Vol 17, No 3 (2021) |
Impact of radiotherapy on long-term treatment outcomes in patients with breast cancer who have undergone simultaneous one-stage and two-stage reconstructive surgeries. Literature review |
(Rus)
|
|
Berestok T.S., Reshetov I.V., Zikiryakhodzhaev A.D., Galkin V.N., Ermoshchenkova M.V., Ablitsova N.V., Vlasova M.Y., Ortabaeva D.R.
|
| Vol 17, No 3 (2021) |
10 years of success achieved by eribulin while treating HER2-negative mBC: from randomized studies to routine practice |
(Rus)
(Eng)
|
|
Kolyadina I.V.
|
| Vol 17, No 2 (2021) |
Lesions of the breast with uncertain malignant potential |
(Rus)
|
|
Vуsotskaya I.V., Gladilina I.A., Kirsanov V.Y., Ponedelnikova N.V., Kim E.A., Ponomarev V.E.
|
| Vol 17, No 2 (2021) |
Ribociclib in the treatment of HR+ HER2-negative metastatic breast cancer: updated results from the randomized clinical trials and their role in the clinical practice |
(Rus)
|
|
Kolyadina I.V.
|
| Vol 17, No 1 (2021) |
Current approaches to the treatment of HER2‑positive breast cancer with brain metastases |
(Rus)
|
|
Semiglazova T.Y., Sharashenidze S.M., Kerimova S.N., Klimenko V.V., Malygin A.Y., Dashyan G. ., Paltuev R.M., Semiglazov V.V., Krivorotko P.V., Novikov S.N., Semiglazov V. .
|
| Vol 17, No 1 (2021) |
[18F]-Fluoroestradiol PET/CT: a modern look at nuclear medicine applications |
(Rus)
|
|
Parnas A.V., Pronin A.I., Ilyakov V.S., Meshcheryakova N.A., Kamolova Z.K., Mikhaylov A.I.
|
| Vol 16, No 4 (2020) |
The role of biomarkers in the early diagnostics of breast cancer |
(Rus)
|
|
Ismagilov A.K., Khuzina D.R., Vanesyan A.S., Zaysteva V.V.
|
| Vol 16, No 4 (2020) |
Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review) |
(Rus)
|
|
Krumin Y.S., Khaylenko V.A., Kozlov N.A., Cheremis G.Y., Petrovskyy A.V., Khaylenko D.V., Artamonova E.V., Kovalenko E.I.
|
| Vol 16, No 4 (2020) |
Occult breast cancer. Literature review and case series |
(Rus)
|
|
Khodorovich О.S., Solodkiy V.A., Kalinina-Masri A.A., Bliznyukov О.Р., Sherstneva T.V., Lazukina I.A., Kanakhina L.B.
|
| Vol 16, No 4 (2020) |
Hereditary breast cancer and ovarian cancer: clinical course and treatment |
(Rus)
|
|
Semiglazov V.V., Protasova A.Е., Kalikeev G.K.
|
| Vol 16, No 1 (2020) |
PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use |
(Rus)
|
|
Dolgasheva D.S., Pevzner A.M., Ibragimova M.K., Litvyakov N.V., Tsyganov M.M.
|
| Vol 16, No 1 (2020) |
Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer |
(Rus)
|
|
Nasretdinov A.F., Sultanbaeva N.I., Musin S.I., Pushkarev A.V., Menshikov K.V., Pushkarev V.A., Sultanbaev A.V.
|
| Vol 16, No 1 (2020) |
Features of ultrasound of endometrial pathological conditions in breast cancer patients receiving tamoxifen: a review of literature |
(Rus)
|
|
Chekalova M.A., Borisova M.I.
|
| Vol 16, No 1 (2020) |
Strategy of post-neoadjuvant treatment of patients with residual breast cancer |
(Rus)
|
|
Semiglazov V.V., Natopkin A.A.
|
| Vol 15, No 4 (2019) |
Biological rationale for patient-specific treatment of breast cancer. Analysis of new data for breast cancer |
(Rus)
|
|
Paltuev R.M.
|
| Vol 15, No 4 (2019) |
General recommendations for the management of breast cancer (St. Gallen Expert Consensus developed at the 16th th International Breast Cancer Conference) |
(Rus)
|
|
Semiglazov V.F., Paltuev R.M., Semiglazov V.V.
|
| Vol 14, No 4 (2018) |
The modern trends in diagnosis and treatment of primary operable breast cancer |
(Rus)
|
|
Mekhtieva N.I.
|
| Vol 14, No 3 (2018) |
Main risk factors for breast cancer and proposals for its prevention |
(Rus)
|
|
Portnoy S.M.
|
| Vol 14, No 3 (2018) |
Role of microRNAs in breast cancer development and their potential as biomarkers |
(Rus)
|
|
Grishina K.A., Khaylenko V.A., Khaylenko D.V., Karpukhin A.V.
|
| Vol 14, No 3 (2018) |
Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer |
(Rus)
|
|
Slonimskaya E.M., Doroshenko A.V., Kazantseva P.V., Tarabanovskaya N.A., Vernadsky R.Y.
|
| Vol 14, No 3 (2018) |
Breast cancer in young patients. Peculiarities of prognosis and adjuvant hormone therapy (a literature review) |
(Rus)
|
|
Kravchenko D.N., Parokonnaya A.A., Nechushkin M.I., Nikitina E.A., Hakurinova N.D.
|
| Vol 14, No 2 (2018) |
VACUUM-ASSISTED ASPIRATION BIOPSY: MINIMALLY INVASIVE TREATMENT FOR BENIGN BREAST TUMORS (A LITERATURE REVIEW) |
(Rus)
|
|
Levchenko K.F., Baranov A.I.
|
| Vol 14, No 2 (2018) |
SURGICAL TREATMENT OF BREAST CANCER: FROM THE CONCEPT OF ERADICATION TO AESTHETIC SURGERY |
(Rus)
|
|
Vorotnikov I.K., Letyagin V.P., Vysotskaya I.V., Sel’chuk V.Y., Burov D.A., Pavlov A.V.
|
| Vol 14, No 2 (2018) |
THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF EARLY-STAGE HORMONE-SENSITIVE BREAST CANCER |
(Rus)
|
|
Koroleva I.A., Kopp M.V.
|
| Vol 14, No 2 (2018) |
PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER |
(Rus)
|
|
Kozyavin N.A., Semiglazova T.Y.
|
| Vol 14, No 1 (2018) |
INTERCELLULAR AND CELL-MATRIX INTERACTIONS IN BREAST CARCINOMA: THE PRESENT STATE OF PROBLEM |
(Rus)
|
|
Mnikhovich M.V., Mishinа E.S., Bezuglova T.В., Bun’kov K.V.
|
| Vol 14, No 1 (2018) |
BIOLOGICAL AND SYNTHETIC MATERIALS IN RECONSTRUCTIVE SURGERY FOR BREAST CANCER TREATMENT (LITERATURE REVIEW) |
(Rus)
|
|
Zikiryakhodzhaev A.D., Shirokikh I.M., Ablitsova N.V., Ermoshchenkova M.V., Kharchenko N.V., Saribekyan E.K., Tukmakov A.Y., Sukhot’ko A.S., Zapirov G.M., Khakimova S.G.
|
| Vol 14, No 1 (2018) |
SENTINEL LYMPH NODE BIOPSY: HISTORY AND CURRENT CONCEPTS |
(Rus)
|
|
Ismagilov A.K., Asnina N.G., Azarov G.A.
|
| Vol 14, No 1 (2018) |
MODERN VIEWS ON THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF PATIENTS WITH HORMONE-DEPENDENT BREAST CANCER: SABCS-2017 NEWS |
(Rus)
|
|
Bozhok A.A.
|
| Vol 14, No 1 (2018) |
PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY |
(Rus)
|
|
Artamonova E.V.
|
| Vol 13, No 4 (2017) |
CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER |
(Rus)
|
|
Imyanitov E.N., Semiglazova T.Y.
|
| Vol 13, No 3 (2017) |
DIAGNOSIS AND PREVENTION OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER FROM THE STANDPOINT OF AN ONCOLOGIST AND A CARDIOLOGIST |
(Rus)
|
|
Semiglazova T.Y., Teletaeva G.M., Kozyavin N.A., Zagatina A.V.
|
| Vol 13, No 3 (2017) |
PALBOCICLIB IN COMBINATION WITH HORMONE THERAPY FOR LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER: NEW HIGHLY EFFECTIVE STRATEGY OF DRUG TREATMENT |
(Rus)
|
|
Artamonova E.V.
|
| Vol 13, No 2 (2017) |
THE BLOOD SUPPLY TO THE NIPPLE-AREOLAR COMPLEX (A LITERATURE REVIEW) |
(Rus)
|
|
Egorov Y.S., Dzottsoev A.K.
|
| Vol 13, No 1 (2017) |
Clinical and morphological characteristics of skin and subcutaneous fat damage after surgical treatment and radiation therapy in patients with breast cancer (literature review) |
(Rus)
|
|
Topuzov E.E., Agishev T.T., Bozhok A.A., Dashyan G.A., Sadygova S.N., Prikhod’ko E.V., Arshba E.A.
|
| 1 - 73 of 73 Items |
|
